Blister beetle 2026-10-31
A beetle of the family Meloidae, several members of which supply cantharidin.
Cantharides 2026-10-31
Historical dried blister-beetle medicinal material containing cantharidin. Its toxicity differs from the efficacy question for a particular regulated topical product.
Molluscum contagiosum 2026-10-31
A viral skin disease; a current approved topical cantharidin indication, distinct from the remote diseases for which historical counterirritation was advocated.
Ordinary cantharides blisters owe their activity to cantharidin; other blistering methods act through different chemical irritants or through physical injury. There is no single substance common to every way of raising a blister.
In the standard historical preparations, the dried blister beetle supplies cantharidin. A plaster, blistering paper, blistering liquid, or cantharides vinegar is a different vehicle for delivering the same vesicant to the skin. Extracting the beetle into a liquid does not make the solvent the specific active principle. The 1867 British Pharmacopoeia includes Emplastrum cantharidis, Charta epispastica, Liquor epispasticus and Acetum cantharidis.[ref]
Other historical means need separate explanations. Moist mustard develops an irritant volatile product, principally allyl isothiocyanate from black mustard; its usual intended effect is reddening, with prolonged exposure capable of more destructive injury. This differs from the fixed mustard seed oil: the irritant volatile product develops after moistening the powdered seeds.[ref] Strong Ammonia acts as an alkaline irritant. Croton oil can produce an inflammatory and pustular eruption, which is not the same lesion as a clean cantharides blister. A sufficiently hot object or hot liquid raises a blister through thermal damage, without a medicinal active molecule. These differences matter because erythema, a fluid-filled blister, a pustule, and tissue destruction are not interchangeable endpoints.
For cantharidin, the modern tissue explanation involves loss of adhesion between epidermal cells, including disruption of desmosomes, with separation within the epidermis and accumulation of fluid. The blister is therefore a local lesion of cell adhesion accompanied by inflammation, rather than a pocket containing disease drawn from a remote organ. The FDA review describes this acantholysis and distinguishes it from the incompletely understood mechanism of clinical benefit in a particular modern indication.[ref]
A nineteenth-century answer would usually describe two supposed routes to benefit:
  • Counterirritation. A new superficial irritation was believed to relieve a deeper painful or inflamed part by altering nervous activity and the distribution of blood. A physiologically intelligible component is that input from sensory nerves can change pain processing and reflex output. That does not establish the stronger historical claim that creating an artificial inflammation cures an unrelated internal inflammation.
  • Serous drainage or “depletion”. Fluid escaping from the raised blister was thought to remove fluid from the circulation and reduce local fullness. Fluid does indeed leave damaged blood vessels and collect in the blister, but the observation alone does not demonstrate beneficial selective removal of a disease-producing substance. Maintaining a draining sore was a historical practice, not a consequence required by current physiology.
Thus the demonstrable processes are local injury, inflammation, fluid exudation, and sensory stimulation; the broad historical claims of remote benefit require separate evidence. Current approved topical cantharidin use for molluscum contagiosum does not validate nineteenth-century blistering for diseases of internal organs. The modern label explicitly states that the mechanism of action in molluscum contagiosum is unknown and documents local skin reactions.[ref]